"It's not drug availability alone but also the ability of target cells to process it is critical to eventual treatment outcomes" #gemcitabine in #PancreaticCancer@Cancers_MDPI https://t.co/f96rpItI4M
Our latest review article provides overview of the latest findings on how stellate sells support metabolic reprogramming and promote gemcitabine chemoresistance in #PancreaticCancer ##mdpicancers via @Cancers_MDPI https://t.co/ZqZ5YHf4z6
Lauch of our new National Competence Network for Pancreas Cancer Research funded by @Kreftforeningen and with @UniOslo_MED@Oslounivsykehus@UiB @sus_no. This focussed effort on #PancreaticCancer will bring together surgeons, oncologists, researchers, geneticists and user reps.
Lauch of our new National Competence Network for Pancreas Cancer Research funded by @Kreftforeningen and with @UniOslo_MED@Oslounivsykehus@UiB @sus_no. This focussed effort on #PancreaticCancer will bring together surgeons, oncologists, researchers, geneticists and user reps.